PD05: Infections/Inflammation/Cystic Disease of the Genitourinary Tract: Interstitial Cystitis

Friday, April 28, 2023

9:30 AM – 11:30 AM CST

Location: S404A

CE: 1

Podium Session Moderator(s)

Jeremy Burton, PhD

Lawson Health Research Institute, Western University
Henry Lai, MD

Professor of Urology and Anesthesiology
Washington University School of Medicine
John Lavelle, MD (he/him/his)

Director Neurourology, Urodynamics and Voiding Dysfunction, VA Palo Alto HCS
Stanford University

Presentations:

9:30 AM – 9:40 AM CST

PD05-01: Distinct Phenotypes of Bladder Pain Identified in the Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Dataset
Podium Presenter: Oluwarotimi S. Nettey, MD, MHS
9:40 AM – 9:50 AM CST

PD05-02: Small Fiber Polyneuropathy as a Therapeutic Target for Patients With Interstitial Cystitis/Bladder Pain Syndrome
Podium Presenter: Wyatt Whitman, MD
9:50 AM – 10:00 AM CST

PD05-03: Bladder-directed versus pelvic floor therapy in women with interstitial cystitis/bladder pain syndrome: preliminary results
Podium Presenter: Kenneth Michael Peters, MD – Oakland University William Beaumont School of Medicine
10:00 AM – 10:10 AM CST

PD05-04: The Association of Self-Reported Recurrent Urinary Tract Infections and Hormonally Mediated Vestibulodynia
Podium Presenter: Ryan Isaac Nasseri, MD, BS – University of California, San Diego
10:10 AM – 10:20 AM CST

PD05-05: The real-life practice of intravesical botulinum toxin A injection for interstitial cystitis/bladder pain syndrome - Satisfaction rate and predictive factors
Podium Presenter: Yuan-Hong Jiang, MD
10:20 AM – 10:30 AM CST

PD05-06: Infection phenotype in Interstitial cystitis/bladder pain syndrome : Does bacterial-induced mucosal cellular immune imbalance hypersensitivity explain response to MV140 recurrent UTI vaccine?
Podium Presenter: Curtis J. Nickel, MD, FRCSC (he/him/his)
10:30 AM – 10:40 AM CST

PD05-07: Th1/17 polarization and potential treatment by an anti-interferon-γ DNA aptamer in Hunner-type interstitial cystitis
Podium Presenter: Kaori Harada, PHD – Tagcyx Biotechnologies Inc.
10:40 AM – 10:50 AM CST

PD05-08: Elevated FM/a Blood Test in Patients with Interstitial Cystitis / Bladder Pain Syndrome
Podium Presenter: Claire Burton, MD – Stanford University
10:50 AM – 11:00 AM CST

PD05-09: EFFECTS OF SUNOBINOP (V117957) IN A MODEL OF ACUTE CYSTITIS INDUCED BY CYCLOPHOSPHAMIDE
Podium Presenter: Garth Whiteside
11:00 AM – 11:10 AM CST

PD05-10: Longitudinal Analysis of Repeat Hydrodistension in Interstitial Cystitis/Bladder Pain Syndrome Patients
Podium Presenter: Maxwell Louis Sandberg, MD,MS,BS
11:10 AM – 11:20 AM CST

PD05-11: Serum Anandamide and Lipids Associated with Linoleic Acid Can Distinguish Interstitial Cystitis and Bladder Pain Syndrome from Overactive Bladder
Podium Presenter: Kazumasa Torimoto, MD
11:20 AM – 11:30 AM CST

PD05-12: Why Augmentation Cystoplasty Alone(ACA) works in intractable Interstitial Cystitis/Bladder pain Syndrome(IC/BPS)?
Podium Presenter: Nagendranath Mishra, MD